Leukemia inhibitory factor: Recent advances and implications in biotechnology

Area of Science:

• Biochemistry and Molecular Biology
• Immunology
• Neuroscience

Background:

• Leukemia inhibitory factor (LIF) is a pleiotropic cytokine with diverse biological functions.
• LIF plays roles in various physiological processes, including inflammation and cancer development.
• Emerging research highlights LIF's function as a neurotrophic factor, suggesting potential in neurological conditions.

Purpose of the Study:

• To review the multifaceted roles of Leukemia inhibitory factor (LIF) in health and disease.
• To explore the therapeutic potential of LIF, particularly in neurological and psychological disorders.
• To assess the current status of LIF in clinical applications and future prospects.

Main Methods:

• Literature review of existing studies on Leukemia inhibitory factor (LIF).
• Analysis of LIF's functions in inflammation, cancer, and neurobiology.
• Evaluation of completed and ongoing clinical trials involving LIF.

Main Results:

• LIF exhibits a broad range of functions, impacting inflammation and cancer.
• Recent investigations reveal LIF's neurotrophic properties, indicating potential for treating central nervous system disorders.
• A limited number of clinical trials have been completed, highlighting a gap in therapeutic applications.

Conclusions:

• Leukemia inhibitory factor (LIF) holds significant promise as a therapeutic agent for a spectrum of diseases.
• Further clinical investigation and development are crucial to realize LIF's full therapeutic potential.
• Increased interest from biotechnology firms suggests a promising future for LIF in disease management.